Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-22-006948)

Filing Details

Accession Number:: 0001567619-22-006948
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-14 21:22:50
Reporting Period:: 2022-03-14

Accepted Time:: 2022-03-14 21:22:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305253	Eiger Biopharmaceuticals Inc.	EIGR	Biological Products, (No Disgnostic Substances) (2836)	361004130

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1762893	Sriram Ryali	C/O Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-14	2,266	$5.60	41,566	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.